Rowley Law PLLC Investigating Alleged Securities Violations at Sage Therapeutics Acquisition Rowley Law PLLC is probing Sage Therapeutics for possible breaches of securities law amid its acquisition by Supernus Pharmaceuticals, valued at up to $795 million.

Rowley Law PLLC Investigating Alleged Securities Violations at Sage Therapeutics Acquisition #United_States #New_York #Rowley_Law_PLLC #Sage_Therapeutics #Supernus_Pharmaceuticals